| Literature DB >> 34199331 |
Anita Nyarkoa Walker1, Ting Zhang2, Xue-Qing Peng1, Jin-Jin Ge1, Hai Gu3, Hua You1.
Abstract
BACKGROUND: With the continuous large-scale development of the COVID-19 vaccine, the acceptance of vaccination and its influencing factors at the individual level have become crucial to stemming the pandemic. This study aims to explore the factors that influence the acceptance of the COVID-19 vaccine among international college students.Entities:
Keywords: China; cross-sectional study; health behavior theory; vaccine acceptance
Year: 2021 PMID: 34199331 PMCID: PMC8228371 DOI: 10.3390/vaccines9060585
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Demographic characteristics of the respondents (n = 330).
| Variables | Frequency | Percentage | |
|---|---|---|---|
| Gender | |||
| Male | 180 | 54.5 | |
| Female | 150 | 45.5 | |
| Age | |||
| 18–25 | 180 | 54.5 | |
| 26 and Above | 150 | 45.5 | |
| Education | |||
| Undergraduate | 172 | 52.1 | |
| Postgraduate and above | 158 | 47.9 | |
| Current Place of Residence | |||
| In China | 192 | 58.2 | |
| Outside China | 138 | 41.8 | |
| Continent of origin | |||
| Europe | 7 | 2.1 | |
| Asia | 151 | 45.8 | |
| Africa | 165 | 50.0 | |
| America | 3 | 0.9 | |
| Oceania | 4 | 1.2 | |
| Diagnosed with chronic disease | |||
| Yes | 14 | 4.2 | |
| No | 316 | 95.8 | |
| General health status | |||
| Very good/good | 330 | 94.8 | |
| Fair/Bad | 17 | 5.20 | |
| Average monthly expense | |||
| Less than 1000 CNY (152.6 USD) | 102 | 30.9 | |
| Between 1000 and 3000 CNY (152.6–457.8 USD) | 188 | 57.0 | |
| More than 3000 CNY (457.8 USD) | 40 | 12.1 |
Knowledge on general vaccinations and the COVID-19 vaccine.
| Variable | Correct (%) | Wrong (%) |
|---|---|---|
| Vaccination is highly recommended to high-risk individuals (Individuals more vulnerable to the infection). | 246 (74.5) | 84 (25.5) |
| Can vaccination protect the people around you? | 256 (77.6) | 74 (22.4) |
| Do individuals with (a supposed) strong immune system need vaccination against diseases? | 242 (73.3) | 88 (26.7) |
| Is natural protection from being infected with the disease better than protection from vaccination? | 231 (70.0) | 99 (30.0) |
| Does vaccination make people sterile? | 148 (44.8) | 182 (55.2) |
| Vaccine-preventable diseases are not very dangerous; hence, there is no need to be vaccinated. | 232 (70.3) | 98 (29.7) |
| Vaccinations are not effective and do not prevent diseases. | 262 (79.4) | 68 (20.6) |
| The recommended dose interval of the COVID-19 vaccine. | 196 (59.4) | 134 (40.6) |
| The group of people recommended to get the COVID-19 vaccine. | 73 (22.1) | 257 (77.9) |
| The main side effects of the COVID-19 vaccine. | 88 (26.7) | 242 (73.3) |
| Should a person previously infected with COVID-19 still be vaccinated? | 201 (60.9) | 129 (39.1) |
| Should a person currently infected with COVID-19 still be vaccinated? | 90 (27.3) | 240 (72.7) |
| Do you think the COVID-19 vaccination can protect against COVID-19 infection? | 213 (64.5) | 117 (35.5) |
| Does a person still need to practice preventive measures such as wearing a face mask, washing hands, and social distancing after vaccination? | 280 (84.8) | 50 (15.2) |
Health beliefs and vaccine acceptance.
| Variables | Strongly Agree (%) | Agree (%) | Neutral (%) | Disagree (%) | Strongly Disagree (%) |
|---|---|---|---|---|---|
| Susceptibility | |||||
| There is a possibility of being infected with COVID-19 currently | 41 (12.4) | 118 (35.8) | 104 (31.5) | 35 (10.6) | 32 (9.7) |
| I worry about the likelihood of being infected with COVID-19 | 32 (9.7) | 102 (30.9) | 109 (33.0) | 57 (17.3) | 30 (9.1) |
| The chance of me contacting COVID-19 is high | 15 (4.5) | 37 (11.2) | 112 (33.9) | 97 (29.4) | 69 (20.9) |
| I am concerned about those around me being infected with COVID-19 | 50 (15.2) | 91 (27.6) | 112 (33.9) | 45 (13.6) | 32 (9.7) |
| People could have been infected without symptoms | 101 (30.6) | 126 (38.2) | 66 (20.0) | 19 (5.8) | 18 (5.5) |
| Severity | |||||
| The complications of COVID-19 are very serious | 87 (26.4) | 161 (48.8) | 59 (17.9) | 14 (4.2) | 9 (2.7) |
| I will be very sick if I am infected with COVID-19 | 32 (9.7) | 107 (32.4) | 129 (39.1) | 42 (12.7) | 20 (6.1) |
| COVID-19 infectivity is very high | 62 (18.8) | 142 (43.0) | 86 (26.1) | 28 (8.5) | 12 (3.6) |
| COVID-19 will cause serious damage to my health | 55 (16.7) | 119 (36.1) | 108 (32.7) | 31 (9.4) | 17 (5.2) |
| If I catch the disease, I will be threatened with death | 26 (7.9) | 53 (16.1) | 141 (42.7) | 72 (21.8) | 38 (11.5) |
| Benefits | |||||
| Being vaccinated is a great idea, because it will prevent me from the fear of being infected with COVID-19 | 71 (21.5) | 138 (41.8) | 91 (27.6) | 21 (6.4) | 9 (2.7) |
| Vaccination reduces my chance of being infected with COVID-19 | 79 (23.9) | 142 (43.0) | 82 (24.8) | 19 (5.8) | 8 (2.4) |
| The vaccine can prevent COVID-19 complications | 62 (18.8) | 125 (37.9) | 106 (32.1) | 27 (8.2) | 10 (3.0) |
| Vaccines prevents diseases effectively | 83 (25.2) | 145 (43.9) | 87 (26.4) | 10 (3.0) | 5 (1.5) |
| Vaccinations will allow me to lead my social life in safety | 71 (21.5) | 118 (35.8) | 110 (33.3) | 19 (5.8) | 12 (3.6) |
| Barriers | |||||
| I worry that my normal life will be interrupted by the side effects of the COVID-19 vaccine | 37 (11.2) | 84 (25.5) | 140 (42.4) | 51 (15.5) | 18 (55.5) |
| The COVID-19 vaccine will interrupt my normal life activities | 57 (17.3) | 136 (41.2) | 111 (33.6) | 17 (5.2) | 9 (2.7) |
| The COVID-19 vaccine’s safety is a concern to me | 65 (19.7) | 155 (47.0) | 92 (27.9) | 12 (3.6) | 6 (1.8) |
| I am concerned about the authenticity of the COVID-19 vaccine | 74 (22.4) | 123 (37.3) | 106 (32.1) | 18 (5.5) | 9 (2.7) |
| I am concerned about the affordability of the COVID-19 vaccine | 45 (13.3) | 87 (26.4) | 144 (43.6) | 37 (11.2) | 17 (5.2) |
| Cues to action | |||||
| If I am given adequate information about the COVID-19 vaccine I will be vaccinated | 77 (23.3) | 148 (44.8) | 77 (23.3) | 18 (5.5) | 10 (3.0) |
| I will take the vaccine when someone I know is taking it | 28 (8.5) | 103 (31.2) | 120 (36.4) | 54 (16.4) | 25 (7.6) |
| If the government gives free vaccinations, I will be vaccinated | 67 (20.3) | 101 (30.6) | 113 (34.2) | 30 (9.1) | 19 (5.8) |
| I have watched media reports promoting COVID-19 vaccinations | 61 (18.5) | 138 (41.8) | 104 (31.5) | 19 (5.8) | 8 (2.4) |
| My family, friends, and peers recommend taking the COVID-19 vaccine | 44 (13.3) | 89 (27.0) | 130 (39.4) | 51 (15.5) | 16 (4.8) |
| Vaccine acceptance | |||||
| I would like to receive the COVID-19 vaccine right away | 55 (16.7) | 96 (29.1) | 126 (38.2) | 29 (7.3) | 24 (7.3) |
| I still have some concerns, so I don’t want to receive the COVID-19 vaccine right away | 43 (13.0) | 61 (18.5) | 118 (35.8) | 69 (20.9) | 39 (11.8) |
| I’m willing to receive the COVID-19 vaccine even if I’m required to pay for it | 37 (11.2) | 89 (27.0) | 139 (42.1) | 38 (11.5) | 27 (8.2) |
| I’m still hesitant about the COVID-19 vaccine | 37 (11.2) | 64 (19.4) | 127 (38.5) | 66 (20.0) | 36 (10.9) |
| I’m willing to receive the COVID-19 vaccine no matter what | 31 (9.4) | 74 (22.4) | 141 (42.7) | 49 (14.8) | 35 (10.6) |
Crosstab showing how vaccine acceptance varies across demographics, health beliefs, and knowledge about the COVID-19 vaccine.
| Variable | |||||
|---|---|---|---|---|---|
| Total | COVID-19 Vaccine Acceptance | ||||
| Strongly Agree/Agree | Neutral/Disagree/Strongly Disagree | ||||
| Gender | |||||
| Male | 180 (54.5) | 68 (37.8) | 112 (62.2) | 0.319 | |
| Female | 150 (45.5) | 52 (34.7) | 98 (65.3) | ||
| Age | |||||
| 25 years and Below | 180 (54.5) | 63 (35.0) | 117 (65.0) | 0.326 | |
| 26 years and Above | 150 (45.5) | 57 (38.0) | 93 (62.0) | ||
| Residence | |||||
| Currently in China | 192 (58.2) | 51 (26.6) | 141 (73.4) | <0.001 | |
| Not currently in China | 138 (41.8) | 69 (50.0) | 69 (50.0) | ||
| Educational level | |||||
| Undergraduates | 172 (52.1) | 63 (36.6) | 109 (63.4) | 0.504 | |
| Graduates and Above | 158 (47.9) | 57 (36.1) | 101 (63.1) | ||
| Program of study | |||||
| Medical-related major | 215 (65.2) | 88 (40.9) | 127 (59.1) | 0.012 | |
| Non-Medical related major | 115 (34.8) | 32 (27.8) | 83 (72.2) | ||
| Continent of origin | |||||
| Europe | 7 (2.1) | 2 (28.6) | 5 (71.4) | 0.016 | |
| Asia | 151 (45.8) | 67 (44.4) | 84 (55.6) | ||
| Africa | 165 (50.0) | 50 (30.3) | 115 (69.7) | ||
| America | 3 (1.2) | 0 (0.0) | 3 (100) | ||
| Oceania | 4 (0.3) | 3 (75.0) | 1 (25.0) | ||
| Health status | |||||
| Very Good/Good | 313 (94.8) | 117 (37.4) | 196 (62.6) | 0.078 | |
| Fair/Bad | 17 (5.2) | 3 (17.6) | 14 (82.4) | ||
| Medical history | |||||
| Diagnosed with a chronic disease | 8 (4.2) | 2 (57.1) | 6 (42.9) | 0.400 | |
| Not diagnosed with a chronic disease | 322 (95.8) | 118 (36.6) | 204 (63.4) | ||
| Knowledge | |||||
| Yes | 222 (67.2) | 97 (43.7) | 125 (56.3) | <0.001 | |
| No | 108 (32.8) | 23 (21.3) | 85 (78.7) | ||
| Susceptibility | |||||
| Yes | 128 (38.8) | 63 (49.2) | 65 (50.8) | <0.001 | |
| No | 202 (61.2) | 57 (28.2) | 145 (71.8) | ||
| Severity | |||||
| Yes | 168 (50.9) | 72 (42.9) | 96 (57.1) | 0.008 | |
| No | 162 (49.1) | 48 (29.6) | 114 (70.4) | ||
| Benefits | |||||
| Yes | 213 (64.5) | 107 (50.2) | 106 (49.8) | <0.001 | |
| No | 117 (35.5) | 13 (11.1) | 104 (88.9) | ||
| Barriers | |||||
| Yes | 193 (58.5) | 66 (34.2) | 127 (65.8) | 0.196 | |
| No | 137 (41.5) | 54 (39.4) | 83 (60.6) | ||
| Cues to action | |||||
| Yes | 169 (51.2) | 102 (60.4) | 67 (39.6) | <0.001 | |
| No | 161 (48.8) | 18 (11.2) | 143 (88.8) | ||
Multivariable logistic regression of the factors associated with COVID-19 vaccine acceptance (N = 330).
| Variable | Sig. | Exp(B) | 95% C.I.for EXP(B) | |
|---|---|---|---|---|
| Lower | Upper | |||
| Gender (ref: Male) | 0.708 | 1.121 | 0.617 | 2.036 |
| Age (ref: 25 years and Below) | 0.573 | 0.573 | 0.560 | 1.378 |
| Residence (ref: currently in China) | 0.07 | 0.536 | 0.273 | 1.052 |
| Educational level (ref: undergraduates) | 0.687 | 1.221 | 0.461 | 3.231 |
| Continent of origin (ref: Europe) | 0.996 | |||
| Asia | 0.723 | 1.877 | 0.058 | 60.915 |
| Africa | 0.752 | 1.551 | 0.102 | 23.689 |
| America | 0.804 | 1.407 | 0.095 | 20.872 |
| Oceania | 0.999 | 0 | 0 | . |
| Health status (ref: good/very good) | 0.62 | 1.528 | 0.287 | 8.143 |
| Medical history (ref: diagnosed with a chronic disease reference) | 0.163 | 3.051 | 0.637 | 14.613 |
| Knowledge (ref: No) | 0.344 | 0.724 | 0.371 | 1.413 |
| Perceived susceptibility (ref: No) | 0.353 | 1.34 | 0.723 | 2.484 |
| Perceived severity (ref: No) | 0.678 | 1.139 | 0.616 | 2.107 |
| Perceived benefits (ref: No) | 0.002 | 3.615 | 1.63 | 8.018 |
| Perceived barriers (ref: No) | <0.001 | 0.307 | 0.159 | 0.594 |
| Cues to action (ref: No) | <0.001 | 8.759 | 4.288 | 17.89 |